Weekly albumin-bound paclitaxel/cisplatin versus gemcitabine/cisplatin as first-line therapy for patients with advanced non-small-cell lung cancer: A phase II open-label clinical study

Lignende værker

• A Phase II Study of Gemcitabine, Vincristine, and Cisplatin (Gvp) As Second-Line Treatment for Patients with Advanced Soft Tissue Sarcoma
  af: Luo, Zhiguo, et al.
  Udgivet: (2015)
• Albumin-bound paclitaxel and gemcitabine combination therapy in soft tissue sarcoma
  af: Tian, Zhichao, et al.
  Udgivet: (2020)
• Weekly nanoparticle albumin-bound paclitaxel in combination with cisplatin versus weekly solvent-based paclitaxel plus cisplatin as first-line therapy in Chinese patients with advanced esophageal squamous cell carcinoma
  af: Wang, Hai-ying, et al.
  Udgivet: (2016)
• Gemcitabine enhances the transport of nanovector-albumin-bound paclitaxel in gemcitabine-resistant pancreatic ductal adenocarcinoma
  af: Borsoi, Carlotta, et al.
  Udgivet: (2017)
• Higher rate of skin rash in a phase II trial with weekly nanoparticle albumin-bound paclitaxel and cisplatin combination in Chinese breast cancer patients
  af: Tang, Li Chen, et al.
  Udgivet: (2013)